US Vitamin B4 Prices Strengthen as Higher Chinese Offers Lift Import Costs

US Vitamin B4 (choline chloride) markets stayed firm in the first half of August 2026 as elevated Vitamin B4 upstream costs and higher import replacement costs supported seller resistance. Early August trading followed July’s firmer tone as Chinese suppliers maintained cautious quotations. Higher trimethylamine and ethylene oxide costs kept production economics supported, and US buyers faced increased import costs as Chinese offers remained firm. Nutraceutical and biopharma procurement remained steady, while restocking expectations kept importers focused on prompt availability. The Vitamin B4 market therefore remained firm without a major supply squeeze, as producers continued normal operations but showed limited willingness to reduce offers.

According to ChemAnalyst, Vitamin B4 (Choline Chloride 60%) CFR Los Angeles averaged $1,000.00/MT in July, rising from $980.00/MT in June. July demand was supported by dietary-supplement premixes, immune-health products, and biopharma processing, while importers and distributors reduced forward coverage, tightening prompt availability. The Vitamin B4 market also absorbed higher trans-Pacific freight, lifting landed costs for US buyers. During the first half of August, firm Chinese quotations further increased import replacement costs and kept Vitamin B4 negotiations elevated.

Supply conditions for Vitamin B4 remained broadly stable during the first half of August, with Chinese producers maintaining normal fermentation output and no major shutdowns reported. However, elevated costs for trimethylamine and ethylene oxide continued to provide support. Some Chinese manufacturers maintained weak but stable quotations, while others remained reluctant to offer aggressively, limiting downward flexibility. Higher Chinese Vitamin B4 offers translated into increased import costs for US buyers. Vitamin B4 freight remained another consideration following the sharp Shanghai–Los Angeles increase recorded in July. As a result, the Vitamin B4 supply balance remained manageable, but prompt import economics stayed firm.

Per weekly assessment trends, Vitamin B4 sentiment remained firmer through the first half of August as upstream cost support and stable Chinese offers outweighed improving supply availability. July’s stronger market created a higher starting point, while reduced distributor cover encouraged cautious replenishment. The weekly Vitamin B4 trend for Vitamin B4 indicated that buyers focused on securing material against upcoming requirements rather than waiting for significant concessions. Nevertheless, normal Chinese production prevented the market from becoming materially tight.

Looking ahead to the second half of August, the Vitamin B4 market for Vitamin B4 is expected to remain firm with modest upward pressure. Importer restocking, steady nutraceutical and biopharma consumption, elevated raw-material costs, and firm Chinese quotations should support prices. However, stable production and improved inventory coverage could limit gains. The Vitamin B4 outlook remains cautiously bullish, with freight movements, Chinese export offers, and distributor stocking decisions likely to determine the pace of recovery. These expectations are based on current market trends and remain subject to changing market conditions.